IPOGET 1 GM

Ipoget with mesna 1gm injection is an anticancer and cytoprotective medication classified as an alkylating agent and a hemorrhagic cystitis inhibitor, containing the active ingredients Ifosfamide and Mesna. These medications are prescribed for treating bladder inflammation and cancers affecting soft tissues, germ cells, pancreas, and cervix. Mesna primarily serves to mitigate some adverse effects associated with specific chemotherapy drugs.

If you have experienced an allergic reaction to this medication or any of its components, it should not be administered. This drug may lead to significant bone marrow suppression, resulting in a decreased white blood cell count or low platelet count due to chemotherapy or radiation therapy. If you have received a live virus vaccine, such as measles, mumps, rubella, or chickenpox, you should wait three months before beginning treatment with this drug. Caution is advised when using this medication in individuals with severe kidney or liver disease. Consult your doctor if you are taking any other medications or before using over-the-counter drugs or herbal products. Your physician will assess the potential for interactions with this medication.

Before using this medication, consult your doctor if you are pregnant or planning to conceive. Ipoget with mesna 1gm injection is considered unsafe during pregnancy as it can harm an unborn fetus. Your healthcare provider will perform a pregnancy test prior to initiating treatment with this drug. Discuss effective birth control methods with your doctor and use them for at least two weeks after the last dose. Breastfeeding should be avoided during treatment with this drug, as it may be excreted in small amounts in breast milk.